When hormone therapy stops delivering, the dose is usually the first place to look
Hormone replacement therapy felt like a turning point when it started working. The fatigue lifted. Sleep improved. The persistent weight around your midsection finally started responding to the effort you were already putting in. For the first few months, everything moved in the right direction.
Then something shifted. The improvements plateaued, or a symptom that had resolved quietly returned. You are still on the same protocol, still following the same routine, and yet the results feel like they belong to a different version of the treatment.
This is one of the most common experiences in hormone therapy, and one of the least discussed. A dose that was clinically appropriate six months ago can become insufficient or excessive as your body changes, your metabolism adapts, and the biological environment around those hormones evolves. The patients who get the best long-term outcomes from bioidentical hormone replacement therapy in San Diego are the ones whose protocols are treated as living documents rather than static prescriptions.
Why the right dose today may not be the right dose in six months
Hormones operate within a network. They interact with thyroid function, insulin sensitivity, cortisol output, liver metabolism, nutritional status, and inflammatory signaling. When any of these variables shifts, the way your body processes and responds to supplemental hormones shifts with it.
A woman who begins estrogen therapy during early perimenopause, for example, may still have intermittent ovarian function producing unpredictable surges of endogenous estrogen. The dose that felt right during a low phase may become excessive during a surge, producing symptoms like breast tenderness, bloating, or mood instability that were absent at the start of treatment. As ovarian output continues to decline over the following year, the same patient may then need an upward adjustment to maintain the relief she experienced initially.
In men, testosterone therapy can influence hematocrit, estrogen conversion through aromatase activity, and SHBG levels over time. A starting dose that produced optimal free testosterone at week eight may yield a different hormonal profile at month six as the body recalibrates its binding proteins and metabolic pathways.
This is expected physiology. The body adapts continuously, and a well-managed hormone protocol adapts with it.
The signs your dose needs a clinical reassessment
Hormone imbalance produces recognizable patterns whether levels are too low or too high. The challenge is that some symptoms overlap between the two, which is why bloodwork rather than guesswork should guide every adjustment. The following table outlines common signals organized by whether they tend to indicate underdosing or overdosing across the major hormone categories.
| Hormone | Signs the dose may be too low | Signs the dose may be too high |
| Estrogen | Hot flashes returning, vaginal dryness, sleep disruption, joint stiffness, brain fog | Breast tenderness, bloating, headaches, mood swings, water retention |
| Testosterone | Persistent fatigue, low libido, difficulty building muscle, flat mood | Acne, oily skin, hair thinning, irritability, elevated hematocrit |
| Progesterone | Anxiety, disrupted sleep, spotting, heightened stress response | Excessive drowsiness, depressed mood, bloating, breast fullness |
A single symptom from this table does not confirm a dosing problem on its own. But when two or more symptoms appear together, or when a symptom that had resolved returns after months of stability, the pattern becomes clinically meaningful.
What bloodwork reveals that symptoms alone cannot
Symptoms tell you something has changed. Bloodwork tells you what changed and in which direction. This distinction matters because the same symptom can arise from opposite causes. Fatigue, for instance, can result from testosterone that is too low or from estrogen that is too high. Adjusting the wrong variable based on symptoms alone risks making the problem worse.
At Katalyst Wellness, follow-up panels are built into every hormone therapy protocol. These are not abbreviated checks limited to a single hormone value. They evaluate the full metabolic context in which your hormones are operating, including thyroid markers, fasting insulin, inflammatory indicators, liver function, and hematocrit. You can read more about why we test over 60 biomarkers before and during treatment in our breakdown of the comprehensive bloodwork panel that informs every clinical decision we make.
One marker that deserves specific attention during follow-up is SHBG (sex hormone-binding globulin). SHBG binds to testosterone and estradiol in the bloodstream, and its concentration determines how much of each hormone is actually available to tissues. A patient whose total testosterone looks adequate on paper but whose SHBG has risen significantly since starting therapy may have far less bioavailable hormone than the number suggests. Without measuring SHBG alongside total and free hormone levels, this discrepancy remains invisible.
The variables that shift your hormonal response over time
Dose requirements change because the body changes. Some of these shifts are gradual and predictable. Others are triggered by specific events or lifestyle factors that patients may not connect to their hormone protocol.
Body composition changes. Gaining or losing a meaningful amount of body fat alters aromatase activity, which converts testosterone into estrogen. A man who loses fifteen pounds of visceral fat on a medically supervised weight loss program in San Diego may find that his estrogen levels drop alongside the fat loss, changing the hormonal ratio his original dose was designed to maintain.
Thyroid function. Thyroid hormones influence the metabolic rate at which every cell in the body operates, including the cells that process supplemental hormones. A patient who develops subclinical hypothyroidism while on HRT, which is common in perimenopausal and menopausal women, may experience a decline in treatment effectiveness that has nothing to do with the hormone dose itself and everything to do with impaired cellular metabolism. A full thyroid panel including free T3 and free T4 can identify this pattern when a TSH-only test would miss it entirely.
Stress and cortisol. Prolonged psychological or physical stress elevates cortisol, which competes with progesterone for receptor binding and suppresses thyroid conversion. Patients going through a high-stress period often report that their hormone therapy “stopped working” when in reality the hormonal environment shifted around a dose that remained the same.
Inflammation. Chronic low-grade inflammation blunts hormone receptor sensitivity at the tissue level. Testosterone and estrogen can be circulating at optimal concentrations and still fail to produce their full effect when inflammatory cytokines are interfering with receptor signaling. This is one reason our clinical team evaluates hs-CRP and other inflammatory markers at follow-up, and it is also why some patients benefit from adding targeted interventions such as low dose naltrexone therapy in San Diego to address the inflammatory load that hormone therapy alone cannot resolve.
Seasonal and circadian factors. Vitamin D status fluctuates with sun exposure, and vitamin D functions as a secosteroid hormone that influences testosterone synthesis and immune regulation. Cortisol follows a diurnal rhythm that interacts with progesterone timing. Even sleep architecture, which shifts with aging and hormonal changes, can alter how the body processes an evening progesterone dose compared to six months earlier.
How often should your protocol be reassessed
The standard timeline at Katalyst Wellness follows a structured cadence. Initial follow-up bloodwork is typically drawn six weeks after starting therapy, which allows enough time for levels to stabilize but catches early signals of over- or under-response. Subsequent panels are drawn at regular intervals, with the frequency depending on the complexity of the protocol and the individual patient’s rate of change.
For women navigating perimenopause, more frequent monitoring is often warranted because endogenous hormone production can fluctuate meaningfully from month to month during this transition. Our overview of HRT for perimenopause and menopause in San Diego explains why this phase requires clinical agility rather than a fixed protocol.
For men on testosterone therapy, hematocrit monitoring is particularly important. A 2023 study published in JAMA Network Open analyzed over 5,600 men receiving testosterone therapy and found that those with regular clinical monitoring had significantly lower rates of adverse cardiovascular events compared to men receiving testosterone without structured follow-up (Jasuja et al., JAMA Network Open, 2023). The implication is clear: monitoring is the mechanism that makes hormone therapy safe over time, and dose adjustment is the clinical action that monitoring enables.
| When to contact your provider between scheduled labs. If a symptom that had fully resolved returns and persists for more than two weeks, or if a new symptom emerges that you did not have before starting treatment, do not wait for your next scheduled panel. Contact your clinical team. An interim blood draw can distinguish between a dosing issue, a metabolic shift, or an unrelated cause, and it prevents weeks of unnecessary discomfort. |
What a proper dose adjustment actually involves
Adjusting a hormone dose is a clinical decision that accounts for lab values, symptom patterns, timing of the protocol, and the full metabolic context. It is the opposite of trial and error.
At Katalyst Wellness, an adjustment might involve changing the dose of one hormone while holding others steady to isolate the effect. It might mean shifting the timing or delivery method rather than the amount. It could involve addressing a contributing factor like thyroid function or insulin resistance before changing the hormone dose at all, because correcting the surrounding environment often restores the original protocol’s effectiveness without any hormonal change.
This layered approach is only possible when the clinical team has access to comprehensive data. A narrow hormone panel that measures total testosterone alone, or TSH without free T3 and T4, leaves too many variables unaccounted for. Our San Diego bloodwork diagnostics evaluate over 60 biomarkers specifically because adjustments made with incomplete data often create new problems while attempting to solve the original one.
The role of cellular energy in how well your hormones perform
A dose adjustment assumes that the hormones themselves are the primary variable. In many cases they are. But there is a biological layer beneath hormone signaling that determines how effectively cells respond to hormonal input: cellular energy production.
NAD+ is a coenzyme required for mitochondrial ATP production, sirtuin activation, and DNA repair. NAD+ levels decline with age, and that decline accelerates during periods of stress, poor sleep, and chronic inflammation. When NAD+ is depleted, cells lack the metabolic resources to fully act on the hormonal signals they receive. The result can look identical to a dosing problem: persistent fatigue, sluggish cognition, incomplete recovery, and a general sense that the therapy is underperforming.
For patients whose bloodwork shows well-optimized hormone levels but whose symptoms tell a different story, combining NAD+ and HRT can address the cellular energy deficit that was preventing the hormones from reaching their full effect. This is a clinical decision guided by lab data and symptom assessment, and it illustrates why a perceived dosing failure sometimes has a solution that lies outside the prescription itself.
Why self-adjusting your dose is the wrong approach
Patients who feel their protocol is underperforming sometimes increase their own dose between appointments, reasoning that more hormone will produce more benefit. This logic fails for several reasons.
- Testosterone dose increases without monitoring can raise hematocrit to levels that increase blood viscosity and cardiovascular risk. They can also accelerate estrogen conversion through aromatase, producing the opposite of the intended effect.
- Estrogen adjustments without concurrent progesterone evaluation can create a state of estrogen dominance that worsens sleep, mood, and metabolic function rather than improving them.
The clinical team at Katalyst Wellness, led by Dr. Camhi, treats dose adjustments as precision interventions. Every change is supported by data, monitored for response, and contextualized within the patient’s full health picture. This is the standard that separates optimized hormone therapy from unsupervised prescribing.
| Your protocol should evolve with you. If your hormone therapy felt transformative at the start and has gradually lost its edge, the answer is a reassessment, not resignation. The dose that launched your recovery may simply need refinement as your body has changed around it. Book a consultation with Katalyst Wellness in San Diego and let our clinical team determine exactly what your current bloodwork says and what your next adjustment should look like. |
Frequently asked questions
How do I know if my symptoms are from my dose or something else entirely?
The only reliable way to distinguish between a dosing issue and another contributing factor is comprehensive bloodwork. Symptoms like fatigue, brain fog, and mood instability can arise from thyroid dysfunction, insulin resistance, nutrient deficiencies, or inflammation independently of hormone levels. A full panel eliminates the guesswork.
Can my dose need adjusting even if my labs look normal?
Yes. Laboratory reference ranges represent population averages, not individual optima. A hormone level that falls within the standard range can still be suboptimal for a given patient based on their symptoms, their baseline, and how their body metabolizes that hormone. Functional interpretation of lab values is a core part of the clinical approach at Katalyst Wellness.
Will I need dose adjustments for the rest of my life?
Adjustments become less frequent as your protocol stabilizes and your provider identifies the ranges where you feel and function your best. Most patients experience the highest frequency of changes in the first year, followed by a maintenance phase with periodic reassessment to account for aging, lifestyle shifts, and metabolic changes.
Is it normal to feel worse before feeling better after a dose change?
A brief adjustment period of one to two weeks is common after a dose change, particularly with progesterone or thyroid support. If symptoms persist beyond that window or worsen significantly, your provider should be contacted for an interim evaluation.
Can lifestyle changes reduce the number of dose adjustments I need?
Absolutely. Consistent sleep, regular resistance training, adequate protein intake, stress management, and maintaining a healthy body composition all stabilize the metabolic environment in which your hormones operate. Patients who actively support these foundations tend to require fewer and smaller adjustments over time.
